{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T21:45:22Z","timestamp":1790286322678,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1124\/mol.109.062463","type":"journal-article","created":{"date-parts":[[2010,2,17]],"date-time":"2010-02-17T04:08:15Z","timestamp":1266379695000},"page":"864-873","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"title":["Effects of Corticotropin-Releasing Factor Receptor-1 Antagonists on the Brain Stress System Responses to Morphine Withdrawal"],"prefix":"10.1016","volume":"77","author":[{"given":"Javier","family":"Navarro-Zaragoza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"N\u00fa\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Luisa","family":"Laorden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Victoria","family":"Milan\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/mol.109.062463_bib1","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.neuropharm.2004.06.020","article-title":"Brain substrates for increased drug seeking during protracted withdrawal","volume":"47","author":"Aston-Jones","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1124\/mol.109.062463_bib2","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1146\/annurev.pharmtox.44.101802.121410","article-title":"CRF and CRF receptors: role in stress responsivity and other behaviors","volume":"44","author":"Bale","year":"2004","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1124\/mol.109.062463_bib3","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1172\/JCI33946","article-title":"Making a bad thing worse: adverse effects of stress on drug addiction","volume":"118","author":"Cleck","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1124\/mol.109.062463_bib4","doi-asserted-by":"crossref","first-page":"18649","DOI":"10.1073\/pnas.0506999102","article-title":"The corticotropin-releasing factor receptor-1 pathway mediates the negative affective states of opioid withdrawal","volume":"102","author":"Contarino","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/mol.109.062463_bib5","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1210\/endo.140.1.6415","article-title":"The impact of the nonpeptide corticotropin-releasing hormone antagonist antalarmin on behavioral and endocrine responses to stress","volume":"140","author":"Deak","year":"1999","journal-title":"Endocrinology"},{"key":"10.1124\/mol.109.062463_bib6","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1046\/j.1460-9568.2002.02187.x","article-title":"Neural correlates of the motivational and somatic components of naloxone-precipitated morphine withdrawal","volume":"16","author":"Frenois","year":"2002","journal-title":"Eur J Neurosci"},{"key":"10.1124\/mol.109.062463_bib7","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0014-2999(01)01402-9","article-title":"Involvement of corticotropin-releasing factor receptor subtype 1 in morphine withdrawal regulation of the brain noradrenergic system","volume":"430","author":"Funada","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/mol.109.062463_bib8","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ejphar.2007.11.075","article-title":"Synaptic physiology of central CRH system","volume":"583","author":"Gallagher","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/mol.109.062463_bib9","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0014-2999(94)90755-2","article-title":"Prolonged tolerance, dependence, and abstinence following subcutaneous morphine pellet implantation in the rat","volume":"253","author":"Gold","year":"1994","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/mol.109.062463_bib10","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s00213-006-0562-5","article-title":"Effects of stress modulation on morphine-induced conditioned place preferences and plasma corticosterone levels in Fischer, Lewis, and Sprague-Dawley rat strains","volume":"189","author":"Grakalic","year":"2006","journal-title":"Psychopharmacology"},{"key":"10.1124\/mol.109.062463_bib11","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/cne.902620304","article-title":"Neuropeptide neuronal efferents from the bed nucleus of the stria terminalis and central amygdaloid nucleus to the dorsal vagal complex in the rat","volume":"262","author":"Gray","year":"1987","journal-title":"J Comp Neurol"},{"key":"10.1124\/mol.109.062463_bib12","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1046\/j.1471-4159.2000.0740199.x","article-title":"Role of corticotropin-releasing factor receptor-1 in opiate withdrawal","volume":"74","author":"Iredale","year":"2000","journal-title":"J Neurochem"},{"key":"10.1124\/mol.109.062463_bib13","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1749-6632.1999.tb07876.x","article-title":"Stress, corticotropin-releasing factor, and drug addiction","volume":"897","author":"Koob","year":"1999","journal-title":"Ann NY Acad Sci"},{"key":"10.1124\/mol.109.062463_bib14","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.neuron.2008.06.012","article-title":"A role for brain stress system in addiction","volume":"59","author":"Koob","year":"2008","journal-title":"Neuron"},{"key":"10.1124\/mol.109.062463_bib15","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1210\/endo.141.4.7407","article-title":"Activation of c-Fos expression in hypothalamic nuclei by \u03bc- and \u03ba-receptor agonists. Correlation with catecholaminergic activity in the hypothalamic paraventricular nucleus","volume":"141","author":"Laorden","year":"2000","journal-title":"Endocrinology"},{"key":"10.1124\/mol.109.062463_bib16","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/sj.bjp.0704684","article-title":"Effects of morphine and morphine withdrawal on brainstem neurons innervating hypothalamic nuclei that control the pituitary-adrenocortical axis in rats","volume":"136","author":"Laorden","year":"2002","journal-title":"Br J Pharmacol"},{"key":"10.1124\/mol.109.062463_bib17","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S0022-3565(24)39271-7","article-title":"Changes in catecholaminergic pathways innervating paraventricular nucleus and pituitary-adrenal axis response during morphine dependence: Implication of A1- and A2-adrenoceptors","volume":"293","author":"Laorden","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/mol.109.062463_bib18","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1046\/j.1471-4159.2002.01123.x","article-title":"Morphine withdrawal-induced c-Fos expression in the hypothalamic paraventricular nucleus is dependent on the activation of catecholaminergic neurones","volume":"83","author":"Laorden","year":"2002","journal-title":"J Neurochem"},{"key":"10.1124\/mol.109.062463_bib19","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/j.1471-4159.1993.tb03191.x","article-title":"Corticotropin-releasing factor stimulates catecholamine release in hypothalamus and prefrontal cortex in freely moving rats as assessed by microdialysis","volume":"60","author":"Lavicky","year":"1993","journal-title":"J Neurochem"},{"key":"10.1124\/mol.109.062463_bib20","first-page":"4398","article-title":"Differential role of corticotropin-releasing factor receptor subtypes 1 and 2 in opiate withdrawal and in relapse to opiate dependence","volume":"12","author":"Lu","year":"2000","journal-title":"Eur J Neurosci"},{"key":"10.1124\/mol.109.062463_bib21","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0149-7634(95)00061-5","article-title":"Participation of noradrenergic pathways in the expression of opiate withdrawal: biochemical and pharmacological evidence","volume":"1","author":"Maldonado","year":"1997","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1124\/mol.109.062463_bib22","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1111\/j.1471-4159.2006.04421.x","article-title":"Activation of stress-related hypothalamic neuropeptide gene expression during morphine withdrawal","volume":"101","author":"N\u00fa\u00f1ez","year":"2007","journal-title":"J Neurochem"},{"key":"10.1124\/mol.109.062463_bib23","doi-asserted-by":"crossref","first-page":"3118","DOI":"10.1210\/en.2008-1732","article-title":"Elevated glucocorticoid levels are responsible for induction of tyrosine hydroxylase (TH) mRNA expression, phosphorylation, and enzyme activity in the nucleus of the solitary tract (NTS-A2) during morphine withdrawal","volume":"150","author":"N\u00fa\u00f1ez","year":"2009","journal-title":"Endocrinology"},{"key":"10.1124\/mol.109.062463_bib24","doi-asserted-by":"crossref","first-page":"5780","DOI":"10.1210\/en.2007-0510","article-title":"Regulation of Serine (Ser)-31 and Ser40 tyrosine hydroxylase phosphorylation during morphine withdrawal in the hypothalamic paraventricular nucleus and nucleus tractus solitarius-A2 cell group. Role of ERK1\/2","volume":"148","author":"N\u00fa\u00f1ez","year":"2007","journal-title":"Endocrinology"},{"key":"10.1124\/mol.109.062463_bib25","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0031-6997(25)06673-6","article-title":"Physiology and pharmacology of corticotropin releasing factor","volume":"43","author":"Owens","year":"1991","journal-title":"Pharmacol Rev"},{"key":"10.1124\/mol.109.062463_bib26","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/0006-8993(73)90290-4","article-title":"Isolated removal of hypothalamic or other brain nuclei of the rat","volume":"59","author":"Palkovits","year":"1973","journal-title":"Brain Res"},{"key":"10.1124\/mol.109.062463_bib27","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"2007"},{"key":"10.1124\/mol.109.062463_bib28","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S0006-8993(01)02126-6","article-title":"Effect of novel stressors on gene expression of tyrosine hydroxylase and monoamine transporters in brainstem noradrenergic neurons of long-term repeatedly immobilized rats","volume":"899","author":"Rusnak","year":"2001","journal-title":"Brain Res"},{"key":"10.1124\/mol.109.062463_bib29","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0306-4522(01)00137-3","article-title":"Detection of corticotropin-releasing hormone receptor 1 immunoreactivity in cholinergic, dopaminergic, and noradrenergic neurons of the murine basal forebrain and brainstem nuclei: potential implication for arousal and attention","volume":"104","author":"Sauvage","year":"2001","journal-title":"Neuroscience"},{"key":"10.1124\/mol.109.062463_bib30","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ejphar.2007.05.041","article-title":"The CRF1 receptor antagonist, R121919, attenuates the severity of precipitated morphine withdrawal","volume":"571","author":"Skelton","year":"2007","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/mol.109.062463_bib31","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s00429-008-0191-3","article-title":"Noradrenergic transmission in the extended amygdala: role in increased drug seeking and relapse during protracted drug abstinence","volume":"213","author":"Smith","year":"2008","journal-title":"Brain Struct Funct"},{"key":"10.1124\/mol.109.062463_bib32","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/sj.npp.1300487","article-title":"Buprenorphine and CRF1 antagonists block the acquisition of opiate withdrawal-induced conditioned place aversion in rats","volume":"30","author":"Stinus","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/mol.109.062463_bib33","first-page":"155","article-title":"Role of epinephrine and vasopressin in the control of the pituitary-adrenal response to stress","volume":"44","author":"Tilders","year":"1985","journal-title":"Fed Proc"},{"key":"10.1124\/mol.109.062463_bib34","doi-asserted-by":"crossref","DOI":"10.1126\/science.6267699","article-title":"Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and \u03b2-endorphin","volume":"213","author":"Vale","year":"1981","journal-title":"Science"},{"key":"10.1124\/mol.109.062463_bib35","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/1096-9861(20001211)428:2<191::AID-CNE1>3.0.CO;2-U","article-title":"Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse","volume":"428","author":"Van Pett","year":"2000","journal-title":"J Comp Neurol"},{"key":"10.1124\/mol.109.062463_bib36","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0022-3956(00)00016-9","article-title":"Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression: the first 20 patients treated","volume":"34","author":"Zobel","year":"2000","journal-title":"J Psychiatr Res"},{"key":"10.1124\/mol.109.062463_bib37","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1517\/13543784.13.7.799","article-title":"The therapeutic potential of CRF1 antagonists for anxiety","volume":"13","author":"Zorrilla","year":"2004","journal-title":"Expert Opin Investig Drugs"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24026798?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24026798?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/mol.109.062463","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T09:45:11Z","timestamp":1739958311000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X24026798"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["S0026895X24026798"],"URL":"https:\/\/doi.org\/10.1124\/mol.109.062463","relation":{},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of Corticotropin-Releasing Factor Receptor-1 Antagonists on the Brain Stress System Responses to Morphine Withdrawal","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/mol.109.062463","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2010 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}